| pubmed-article:11806396 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11806396 | lifeskim:mentions | umls-concept:C2926606 | lld:lifeskim |
| pubmed-article:11806396 | lifeskim:mentions | umls-concept:C0012624 | lld:lifeskim |
| pubmed-article:11806396 | lifeskim:mentions | umls-concept:C2607943 | lld:lifeskim |
| pubmed-article:11806396 | lifeskim:mentions | umls-concept:C0872169 | lld:lifeskim |
| pubmed-article:11806396 | lifeskim:mentions | umls-concept:C1548161 | lld:lifeskim |
| pubmed-article:11806396 | lifeskim:mentions | umls-concept:C0302995 | lld:lifeskim |
| pubmed-article:11806396 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:11806396 | pubmed:dateCreated | 2002-1-24 | lld:pubmed |
| pubmed-article:11806396 | pubmed:abstractText | Nuclear medicine procedures can be helpful in diagnosing spine infections. The purpose of the study was to evaluate the findings of positron emission tomography with fluorine-18 fluorodeoxyglucose (FGD-PET) in the detection of spondylodiscitis. We performed FDG-PET in 16 patients with suspected spondylodiscitis. All the patients were operated and underwent histopathological examination. The FDG-PET findings were graded and evaluated by two independent nuclear medicine physicians. Of the 16 patients, 12 had a histopathologically confirmed spondylodiscitis. In all these 12 patients, FDG-PET was true-positive. In the four patients without spondylodiscitis, FDG-PET showed three true-negative and one false-positive result. In spondylodiscitis, the mean standard uptake value (SUV) of FDG was 7.5 (SD+/-3.8). The PET scans depicted the paravertebral soft tissue involvement in cases of spondylodiscitis. Our first results showed that FDG-PET is a very sensitive imaging procedure in the detection of spondylodiscitis. Compared to other nuclear medicine procedures, PET enables a rapid imaging with acceptable radiation dose and high spatial resolution. | lld:pubmed |
| pubmed-article:11806396 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11806396 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11806396 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:11806396 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11806396 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11806396 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11806396 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:11806396 | pubmed:issn | 0940-6719 | lld:pubmed |
| pubmed-article:11806396 | pubmed:author | pubmed-author:BiersackH JHJ | lld:pubmed |
| pubmed-article:11806396 | pubmed:author | pubmed-author:SchmitzAA | lld:pubmed |
| pubmed-article:11806396 | pubmed:author | pubmed-author:GrünwaldFF | lld:pubmed |
| pubmed-article:11806396 | pubmed:author | pubmed-author:GasselFF | lld:pubmed |
| pubmed-article:11806396 | pubmed:author | pubmed-author:RisseJ HJH | lld:pubmed |
| pubmed-article:11806396 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11806396 | pubmed:volume | 10 | lld:pubmed |
| pubmed-article:11806396 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11806396 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11806396 | pubmed:pagination | 534-9 | lld:pubmed |
| pubmed-article:11806396 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:11806396 | pubmed:meshHeading | pubmed-meshheading:11806396... | lld:pubmed |
| pubmed-article:11806396 | pubmed:meshHeading | pubmed-meshheading:11806396... | lld:pubmed |
| pubmed-article:11806396 | pubmed:meshHeading | pubmed-meshheading:11806396... | lld:pubmed |
| pubmed-article:11806396 | pubmed:meshHeading | pubmed-meshheading:11806396... | lld:pubmed |
| pubmed-article:11806396 | pubmed:meshHeading | pubmed-meshheading:11806396... | lld:pubmed |
| pubmed-article:11806396 | pubmed:meshHeading | pubmed-meshheading:11806396... | lld:pubmed |
| pubmed-article:11806396 | pubmed:meshHeading | pubmed-meshheading:11806396... | lld:pubmed |
| pubmed-article:11806396 | pubmed:meshHeading | pubmed-meshheading:11806396... | lld:pubmed |
| pubmed-article:11806396 | pubmed:meshHeading | pubmed-meshheading:11806396... | lld:pubmed |
| pubmed-article:11806396 | pubmed:meshHeading | pubmed-meshheading:11806396... | lld:pubmed |
| pubmed-article:11806396 | pubmed:meshHeading | pubmed-meshheading:11806396... | lld:pubmed |
| pubmed-article:11806396 | pubmed:meshHeading | pubmed-meshheading:11806396... | lld:pubmed |
| pubmed-article:11806396 | pubmed:meshHeading | pubmed-meshheading:11806396... | lld:pubmed |
| pubmed-article:11806396 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11806396 | pubmed:articleTitle | Fluorine-18 fluorodeoxyglucose positron emission tomography findings in spondylodiscitis: preliminary results. | lld:pubmed |
| pubmed-article:11806396 | pubmed:affiliation | Department of Orthopaedics, University of Bonn, Germany. a.schmitz@uni-bonn.de | lld:pubmed |
| pubmed-article:11806396 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11806396 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11806396 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11806396 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11806396 | lld:pubmed |
